Joel Greenblatt fit · Magic Formula - high ROIC + cheap EV/EBIT
Is Soleno Therapeutics, Inc. Common Stock (SLNO) a Joel Greenblatt Stock?
Low Magic Formula score — expensive, low ROIC, or both.
0/100
FNot a fit
1/5 criteria passed
Joel Greenblatt's Criteria, Applied to SLNO
EBIT/EV yield ≥ 10%
key—
ROIC ≥ 25%
key-60.0%
EV/EBIT ≤ 12
-10.2x
Gross margin ≥ 30%
98.1%
Earnings yield ≥ 6%
-3.4%
How SLNO Scores on Other Strategies
Live Financial Snapshot
Market cap
$2.76B
P/E (TTM)
28.8x
ROIC (TTM)
15.35%
Gross margin
98.63%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is SLNO's Joel Greenblatt fit score?
SLNO scores 0/100 on our Joel Greenblatt fit engine — grade F. Low Magic Formula score — expensive, low ROIC, or both.
Does Joel Greenblatt actually own SLNO?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends SLNO.
How often is this score updated?
SLNO's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends SLNO.